Please use this identifier to cite or link to this item:
|Title:||Aspirin and non-aspirin non-steroidal anti-inflammatory drug use and risk of lung cancer|
|Authors:||Lim, W.-Y. |
|Citation:||Lim, W.-Y., Chuah, K.L., Eng, P., Leong, S.S., Lim, E., Lim, T.K., Ng, A., Poh, W.T., Tee, A., Teh, M., Salim, A., Seow, A. (2012-08). Aspirin and non-aspirin non-steroidal anti-inflammatory drug use and risk of lung cancer. Lung Cancer 77 (2) : 246-251. ScholarBank@NUS Repository. https://doi.org/10.1016/j.lungcan.2012.03.005|
|Abstract:||There is evidence that aspirin and non-aspirin non-steroidal anti-inflammatory drug (NSAID) have anti-carcinogenic properties, but their effect on lung cancer, in particular in never-smokers, is unclear. Information on past or current use of anti-inflammatory medication was obtained in 398 Chinese female primary lung cancer cases and 814 controls in a hospital-based study in Singapore. 65% of cases and 88% of controls were never-smokers. Controls were excluded if they had been admitted for conditions associated with aspirin or NSAID use (n= 174). Regular aspirin use (twice a week or more, for a month or more) was associated with a reduced risk of lung cancer (adjusted odds ratio [OR] 0.50, 95% confidence intervals [95%CI] 0.31-0.81 in non-smokers; OR 0.38, 95%CI 0.16-0.93 in smokers). Regular use of non-aspirin NSAID, paracetamol, steroid creams and steroid pills was uncommon and no association with lung cancer was detected. Our results suggest that aspirin consumption may reduce lung cancer risk in Asian women and are consistent with current understanding of the role of cyclooxygenase in lung carcinogenesis. © 2012 Elsevier Ireland Ltd.|
|Source Title:||Lung Cancer|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Jun 21, 2018
WEB OF SCIENCETM
checked on Apr 30, 2018
checked on Jun 1, 2018
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.